Big Data Technology

AI-Powered Drug Discovery: Identifying Safety Red Flags

Unmanageable toxicity accounts for 30% of clinical drug development failures and can cause severe side effects and potential harm to patients. Download our report to see how AI-powered drug discovery can help mitigate late-stage clinical failures and market withdrawals.  

Written by
Elizabeth Bolitho
  • Categories
  • Safety
  • Target Selection
Receive the latest newsletter directly to your inbox

The High Stakes of Toxicity

From Trial-And-Error to Data-Driven Strategies

AI-Powered Insights: Anticipating Safety Issues

Case Study: The Safety-Related Withdrawal of Umbralisib

AI-Powered Drug Discovery: Identifying Safety Red Flags image 0
Figure 1. Dendrogram view of genes and proteins reported to be targeted by umbrasilib.

Conclusion

References

More on Safety